Clinical Trial Update: EXIBIT: Oxaliplatin in Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oxaliplatin for biliary tract cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: COMPLETED